Stock market analysts anticipate Allergan will report full-year earnings of $4.73 per share Feb. 14, according to the Frisco Fastball.
Here's what you should know:
1. Analysts believe Allergan will announce fourth quarter 2017 earnings of $0.83 per share Feb. 14, as well.
2. Analysts believe the company's full-year earnings will increase approximately 13.98 percent, year over year.
3. Based on the projected earnings, 18 analysts awarded Allergan a "buy" rating and eight have deemed it a "hold." No analysts issued a "sell" rating.